Nick Naclerio
Founding Partner at Illumina Ventures
Portola Valley, California
Overview
Work Experience
Founding Partner
2016 - Current
Illumina ventures is an independently managed venture fund with Illumina as its majority limited partner. We invest in companies focused on advancing the field of genomics and pioneering new applications in life sciences research, healthcare, agriculture, environmental science, public safety and personal wellness. We invest primarily in early stage companies and typically syndicate with other leading institutional and strategic investors. www.illuminaventures.com
Illumina Ventures visions is to improve human health by unlocking the power of the genome.
Board Member
2020
Alamar Biosciences develops technologies for the detection and treatment of cancer and other diseases at the earliest possible time.
Raised $222,000,000.00 from Sands Capital Ventures, Pura Vida Investments, Sherpa Healthcare Partners and Qiming Venture Partners.
Board Member
2020
Board Member
2019
Cradle Genomics is a creator of a novel prenatal testing methodology
Raised $23,100,000.00 from Pacific West Bank.
Chairman Of The Board
2018
Board Member
2017
Board Member
2017
Genome Medical is a telegenomics technology and services company allowing access to genomic-based medicine.
Raised $195,744,304.00 from Perceptive Advisors, Amgen Ventures, Alumni Ventures, Illumina Ventures, Casdin Capital, Revelation Partners, Echo Health Ventures, Avestria Ventures, HealthInvest Equity Partners and Kaiser Permanente Ventures.
Board Member
2016
Serimmune is a company that studies immunity to find out how environmental factors affect health and disease.
Raised $21,448,253.00 from Illumina Ventures and Merck.
Board Member
2016
Baebies develops early disease detection and comprehensive diagnostic solutions.
Raised $119,822,099.00 from National Heart, Lung and Blood Institute, CARB-X and One North Carolina Small Business Program.
Board Member
2017 - 2019
Biota is pioneering biosurveillance across industrial sectors
Raised $1,433,559.00 from XSeed Capital and Illumina Ventures.